...
evo-img

Evotec SE ADR, Common Stock

EVO

NSQ

$4.5

-$0.28

(-5.86%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.70B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
81.78K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.98
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.85 L
$12 H
$4.5

About Evotec SE ADR, Common Stock

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameEVOSectorS&P500
1-Week Return2.36%-3.39%0.2%
1-Month Return-13.87%-1.92%2.72%
3-Month Return31.32%-10.54%7.31%
6-Month Return17.16%-4.47%10.44%
1-Year Return-57.26%4.06%27.53%
3-Year Return-79.07%0.94%30.88%
5-Year Return-62.15%36.67%89.21%
10-Year Return115.32%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue446.44M500.92M618.03M751.45M781.43M[{"date":"2019-12-31","value":57.13,"profit":true},{"date":"2020-12-31","value":64.1,"profit":true},{"date":"2021-12-31","value":79.09,"profit":true},{"date":"2022-12-31","value":96.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue313.55M375.18M466.49M577.38M606.38M[{"date":"2019-12-31","value":51.71,"profit":true},{"date":"2020-12-31","value":61.87,"profit":true},{"date":"2021-12-31","value":76.93,"profit":true},{"date":"2022-12-31","value":95.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit132.89M125.74M151.54M174.06M175.05M[{"date":"2019-12-31","value":75.92,"profit":true},{"date":"2020-12-31","value":71.83,"profit":true},{"date":"2021-12-31","value":86.57,"profit":true},{"date":"2022-12-31","value":99.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin29.77%25.10%24.52%23.16%22.40%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":84.33,"profit":true},{"date":"2021-12-31","value":82.37,"profit":true},{"date":"2022-12-31","value":77.82,"profit":true},{"date":"2023-12-31","value":75.26,"profit":true}]
Operating Expenses58.38M73.98M109.86M153.22M282.14M[{"date":"2019-12-31","value":20.69,"profit":true},{"date":"2020-12-31","value":26.22,"profit":true},{"date":"2021-12-31","value":38.94,"profit":true},{"date":"2022-12-31","value":54.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income62.59M48.52M27.32M12.49M(107.09M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":77.52,"profit":true},{"date":"2021-12-31","value":43.65,"profit":true},{"date":"2022-12-31","value":19.96,"profit":true},{"date":"2023-12-31","value":-171.08,"profit":false}]
Total Non-Operating Income/Expense(11.26M)(29.84M)189.00M(179.62M)771.00K[{"date":"2019-12-31","value":-5.96,"profit":false},{"date":"2020-12-31","value":-15.79,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-95.04,"profit":false},{"date":"2023-12-31","value":0.41,"profit":true}]
Pre-Tax Income56.56M25.81M236.98M(153.96M)(103.84M)[{"date":"2019-12-31","value":23.87,"profit":true},{"date":"2020-12-31","value":10.89,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-64.97,"profit":false},{"date":"2023-12-31","value":-43.82,"profit":false}]
Income Taxes19.33M19.55M21.47M21.70M(40.68M)[{"date":"2019-12-31","value":89.1,"profit":true},{"date":"2020-12-31","value":90.12,"profit":true},{"date":"2021-12-31","value":98.95,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-187.48,"profit":false}]
Income After Taxes37.23M6.25M215.51M(175.66M)(63.16M)[{"date":"2019-12-31","value":17.27,"profit":true},{"date":"2020-12-31","value":2.9,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-81.51,"profit":false},{"date":"2023-12-31","value":-29.31,"profit":false}]
Income From Continuous Operations37.23M6.25M215.51M(175.66M)(83.91M)[{"date":"2019-12-31","value":17.27,"profit":true},{"date":"2020-12-31","value":2.9,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-81.51,"profit":false},{"date":"2023-12-31","value":-38.94,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income38.16M6.28M215.51M(175.66M)(83.91M)[{"date":"2019-12-31","value":17.7,"profit":true},{"date":"2020-12-31","value":2.91,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-81.51,"profit":false},{"date":"2023-12-31","value":-38.94,"profit":false}]
EPS (Diluted)1.060.093.42(0.58)(0.29)[{"date":"2019-12-31","value":31,"profit":true},{"date":"2020-12-31","value":2.57,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-16.86,"profit":false},{"date":"2023-12-31","value":-8.47,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

EVO
Cash Ratio 1.13
Current Ratio 2.09
Quick Ratio 1.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

EVO
ROA (LTM) -1.77%
ROE (LTM) -16.25%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

EVO
Debt Ratio Lower is generally better. Negative is bad. 0.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

EVO
Trailing PE NM
Forward PE 59.88
P/S (TTM) 2.13
P/B 1.63
Price/FCF 119
EV/R 2.13
EV/Ebitda NM

FAQs

What is Evotec SE ADR share price today?

Evotec SE ADR (EVO) share price today is $4.5

Can Indians buy Evotec SE ADR shares?

Yes, Indians can buy shares of Evotec SE ADR (EVO) on Vested. To buy Evotec SE ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EVO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Evotec SE ADR be purchased?

Yes, you can purchase fractional shares of Evotec SE ADR (EVO) via the Vested app. You can start investing in Evotec SE ADR (EVO) with a minimum investment of $1.

How to invest in Evotec SE ADR shares from India?

You can invest in shares of Evotec SE ADR (EVO) via Vested in three simple steps:

  • Click on Sign Up or Invest in EVO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Evotec SE ADR shares
What is Evotec SE ADR 52-week high and low stock price?

The 52-week high price of Evotec SE ADR (EVO) is $12. The 52-week low price of Evotec SE ADR (EVO) is $2.85.

What is Evotec SE ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Evotec SE ADR (EVO) is

What is Evotec SE ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Evotec SE ADR (EVO) is 1.63

What is Evotec SE ADR dividend yield?

The dividend yield of Evotec SE ADR (EVO) is 0.00%

What is the Market Cap of Evotec SE ADR?

The market capitalization of Evotec SE ADR (EVO) is $1.70B

What is Evotec SE ADR’s stock symbol?

The stock symbol (or ticker) of Evotec SE ADR is EVO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top